Since ACE2 is the cellular receptor for SARS-COV-2 entry and a main component of the RAAS system, the downregulation of ACE2 expression following a viral infection promotes ACE1/ACE2 imbalance (Beyerstedt et al., 2021b). Here, ACE2 is linked to viral infectious disease.